SEC Filing by Xoma Corp. Reveals Pharmaceutical Preparation Details

Strategic Insights -

Xoma Corp., a pharmaceutical company, made a U.S. Securities and Exchange Commission (SEC) filing on June 17, 2015. The filing, submitted under Form 4, was for a company identified by the SIC code 2834, which pertains to pharmaceutical preparations. The document, filed with the SEC, includes information about the company's ownership structure and the changes in the beneficial ownership of securities.

Key Takeaways:

  • Xoma Corp. is a pharmaceutical company with a SIC code of 2834, indicating its primary focus on pharmaceutical preparations.
  • The SEC filing was made on June 17, 2015, under Form 4, which is used to report changes in the beneficial ownership of securities.
  • The filing is a formal document submitted to the SEC by publicly-traded companies, providing information on the company's ownership structure and securities transactions.
  • The company's contact information is listed as 2910 SEVENTH ST, BERKELEY CA 94710, with a phone number of 5106441170.
  • The filing is a requirement under Section 12 of the Securities Exchange Act of 1934, which mandates the disclosure of beneficial ownership of equity securities.
  • The filing also includes information on the reporting person's relationship to the company, as well as purchases and sales of equity securities.

Statistics:

  • The filing was submitted on June 17, 2015, under Form 4.
  • The company's SIC code is 2834, indicating its primary focus on pharmaceutical preparations.
  • The filing includes information on the company's ownership structure and changes in the beneficial ownership of securities.
  • The SEC file number for this filing is 0000791908-15-000084.
  • The contact information for the company is listed as 2910 SEVENTH ST, BERKELEY CA 94710, with a phone number of 5106441170.

Sources:

  • NewsRx, "Pharma Business Week" article, June 29, 2015 (No specific date provided in the source)
  • U.S. Securities and Exchange Commission, Form 4 filing: Xoma Corp., June 17, 2015 (No specific date provided in the source)
  • U.S. Securities and Exchange Commission, Information on Form 4: http://www.sec.gov/Archives/edgar/data/1416176/0000791908-15-000084-index.html (No specific date provided in the source)
  • U.S. Securities and Exchange Act of 1934, Section 12: (No specific date provided in the source)